ITPKA and lung carcinoma: In addition, Sabine’s team examined ITPKA expression in a variety of solid tumor tissues and cells and found that ITPKA expression was most significantly up-regulated in lung cancer and further highly expressed in metastatic lymph node, suggesting that ITPKA may be a potential target for anti-metastasis therapy against lung cancer [23].